Related Experiment Video
Updated: Jul 10, 2026
09:39
Mapping Dysfunctional Protein-Protein Interactions in Disease
Published on: October 24, 2025
Proteomic analysis of p16ink4a-binding proteins
Elielson Souza-Rodrígues1, Josep M Estanyol, Erica Friedrich-Heineken
1Departament de Biologia Cellular i Anatomia Patològica, Facultat de Medicina, Universitat de Barcelona, Spain.
Proteomics
|October 24, 2007
Summary
The p16(ink4a) tumor suppressor protein interacts with new partners, including PCNA, a key DNA replication factor. This interaction inhibits DNA polymerase activity, revealing novel functions beyond cell cycle control.
Area of Science:
- Molecular Biology
- Cell Biology
- Oncology
Background:
- The p16(ink4a) protein is a crucial tumor suppressor involved in cell cycle control, tumorogenesis, and senescence.
- Its known function involves inhibiting CDK4 and CDK6 kinases, essential for cell cycle progression.
Purpose of the Study:
- To identify novel p16(ink4a)-interacting proteins and elucidate new functions of p16(ink4a).
Main Methods:
- Affinity chromatography using p16(ink4a) coupled to Sepharose 4B.
- Mass spectrometry (MALDI-TOF) for protein identification.
- Western blotting, immunoprecipitation, and immunofluorescence for validation.
Main Results:
- Thirty-one p16(ink4a)-interacting proteins were identified, grouped into functional clusters.
- Proliferating cell nuclear antigen (PCNA) and minichromosome maintenance protein 6 (MCM6) were identified and validated.
- p16(ink4a) directly interacts with PCNA, inhibiting its DNA polymerase activity.
Conclusions:
- p16(ink4a) possesses novel functions beyond cell cycle regulation, including direct interaction with and inhibition of PCNA's polymerase activity.
- These findings expand our understanding of p16(ink4a)'s role in cellular processes and cancer.
